Bicara Therapeutics (BCAX) Accounts Payable

BCAX Annual Accounts Payable

$3.19 M
-$1.95 M-37.98%

01 December 2023

BCAX Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BCAX Quarterly Accounts Payable

$1.96 M
-$2.72 M-58.10%

30 September 2024

BCAX Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BCAX Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-38.0%-
3 y3 years-38.0%-
5 y5 years-38.0%-

BCAX Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-38.0%at low-58.1%at low
5 y5-year-38.0%at low-58.1%at low
alltimeall time-38.0%at low-58.1%at low

Bicara Therapeutics Accounts Payable History

DateAnnualQuarterly
Sept 2024
-
$1.96 M(-58.1%)
June 2024
-
$4.68 M(+47.0%)
DateAnnualQuarterly
Dec 2023
$3.19 M(-38.0%)
$3.19 M
Dec 2022
$5.14 M
-

FAQ

  • What is Bicara Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Bicara Therapeutics?
  • What is Bicara Therapeutics annual accounts payable year-on-year change?
  • What is Bicara Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Bicara Therapeutics?

What is Bicara Therapeutics annual accounts payable?

The current annual accounts payable of BCAX is $3.19 M

What is the all time high annual accounts payable for Bicara Therapeutics?

Bicara Therapeutics all-time high annual accounts payable is $5.14 M

What is Bicara Therapeutics annual accounts payable year-on-year change?

Over the past year, BCAX annual accounts payable has changed by -$1.95 M (-37.98%)

What is Bicara Therapeutics quarterly accounts payable?

The current quarterly accounts payable of BCAX is $1.96 M

What is the all time high quarterly accounts payable for Bicara Therapeutics?

Bicara Therapeutics all-time high quarterly accounts payable is $4.68 M